A comprehensive study has shown that gene editing, specifically gene knockout (KO), with CRISPR-Cas9 can favor cells with mutated forms of genes linked to cancer. The findings highlight the need to monitor patients undergoing CRISPR-Cas9-based gene therapy for cancer-related mutations.
from Top Health News -- ScienceDaily https://ift.tt/3opfL4I
Post a Comment